Form S-3/A - Registration statement under Securities Act of 1933: [Amend]
SEC Accession No. 0001193125-17-022041
Filing Date
2017-01-27
Accepted
2017-01-27 17:02:34
Documents
8

Document Format Files

Seq Description Document Type Size
1 S-3/A d494779ds3a.htm S-3/A 396223
2 EX-5.1 d494779dex51.htm EX-5.1 89373
3 EX-5.2 d494779dex52.htm EX-5.2 13933
4 EX-23.1 d494779dex231.htm EX-23.1 1734
6 GRAPHIC g494779g82f00.jpg GRAPHIC 48697
7 GRAPHIC g494779image1.jpg GRAPHIC 2980
8 GRAPHIC g494779ml.jpg GRAPHIC 3778
9 filename9.htm CORRESP 8141
  Complete submission text file 0001193125-17-022041.txt   587390
Mailing Address 8 CROSS STREET #10-00 SINGAPORE U0 048424
Business Address 8 CROSS STREET #10-00 SINGAPORE U0 048424 617-206-4830
Wave Life Sciences Ltd. (Filer) CIK: 0001631574 (see all company filings)

IRS No.: 000000000 | State of Incorp.: U0 | Fiscal Year End: 1231
Type: S-3/A | Act: 33 | File No.: 333-215428 | Film No.: 17554524
SIC: 2834 Pharmaceutical Preparations